Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Trevogrumab (Synonyms: REGN-1033, REGN1033)

Catalog No. T80951 Copy Product Info
Purity: 95%
🥰Excellent
Trevogrumab (REGN-1033) is a fully human monoclonal antibody specifically designed to target and inhibit the activity of growth differentiation factor 8 (GDF8), which is also known as myostatin and functions as a negative regulator of muscle growth;Trevogrumab is currently under extensive research of sarcopenia, a complex condition characterized by progressive and generalized loss of skeletal muscle mass and function often associated with aging, wasting atrophy, various chronic diseases, and significant alterations in dietary and nutritional intake.

Trevogrumab

Copy Product Info
🥰Excellent
Catalog No. T80951
Synonyms REGN-1033, REGN1033

Trevogrumab (REGN-1033) is a fully human monoclonal antibody specifically designed to target and inhibit the activity of growth differentiation factor 8 (GDF8), which is also known as myostatin and functions as a negative regulator of muscle growth;Trevogrumab is currently under extensive research of sarcopenia, a complex condition characterized by progressive and generalized loss of skeletal muscle mass and function often associated with aging, wasting atrophy, various chronic diseases, and significant alterations in dietary and nutritional intake.

Trevogrumab
Cas No. 1429201-24-0
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$415-In Stock
5 mg$1,230-In Stock
10 mg$1,650-In Stock
25 mg$2,450-In Stock
50 mg$3,290-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.6% (SDS-PAGE); 95.9% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Trevogrumab (REGN-1033) is a fully human monoclonal antibody specifically designed to target and inhibit the activity of growth differentiation factor 8 (GDF8), which is also known as myostatin and functions as a negative regulator of muscle growth;Trevogrumab is currently under extensive research of sarcopenia, a complex condition characterized by progressive and generalized loss of skeletal muscle mass and function often associated with aging, wasting atrophy, various chronic diseases, and significant alterations in dietary and nutritional intake.
In vitro
Human skeletal myoblasts were treated with Trevogrumab (40 nM, 30 minutes), and the target protein levels were detected by Western Blot.
Results: Trevogrumab effectively inhibited myostatin-induced Smad2/3 activation, showing high affinity and specificity. [1]
In vivo
Trevogrumab (0.1-30 mg/kg, subcutaneously, twice a week for 4 weeks) treated mice resulted in a significant increase in gastrocnemius (GA) and tibialis anterior (TA) muscle weight (~20%) and an increase in myofiber area (~15%).[1]
SynonymsREGN-1033, REGN1033
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetGDF8/Myostatin
Chemical Properties
Molecular Weight144.02 kDa
Cas No.1429201-24-0
Antibody Information
IsotypeHuman IgG4 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Trevogrumab | purchase Trevogrumab | Trevogrumab cost | order Trevogrumab | Trevogrumab in vivo | Trevogrumab in vitro | Trevogrumab molecular weight